Mycobacterium fortuitum skin infection occurring after a facelift;Infection cutanée à Mycobacterium fortuitum après lifting

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 2, 2004, Pages 198-200

  Angeli, K ^a   Lacour, J P ^a   Mantoux, F ^a   Roujea, J C ^b   Andre P ^c   Truffot Pernot, C ^d   Ortonne, J P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b CHU de Creteil   (France)

^c Department of research and high education   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; IMIPENEM;

ABSCESS; AGED; ARTICLE; CASE REPORT; ECHOGRAPHY; FEMALE; HUMAN; MYCOBACTERIUM FORTUITUM; POLYMERASE CHAIN REACTION; RADIODENSITOMETRY; RHYTIDOPLASTY; SKIN INFECTION; SKIN NECROSIS;

EID: 1542510877     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(04)93571-5     Document Type: Article

References (15)

1. Clegg HW, Foster MT, Sanders WE, Baine WB. Infection due to the microorganisms of the Mycobacterium fortuitum complex after augmentation mammoplasty: clinical and epidemiological features. J Infect Dis 1983;147:427-33.
2. Behroozan DS, Christian MM, Moy RL. Mycobacterium fortuitum following neck liposuction: a case report. Dermatol Surg 2000;26:598-90.
3. Murillo J, Torres J, Bofill L, Rios-Fabra A, Irausquin E, Isturiz R et al. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. Arch Dermatol 2000;136:1347-52.
4. Rao J, Golden TA, Fitzpatrick RE. Atypical mycobacterial infection following blepharoplasty and full-face skin resurfacing with CO2 laser. Dermatol Surg 2002;768-71.
5. Kullavavanijaya P. Atypical mycobacterial cutaneous infection. Clin Dermatol 1999;17:153-8.
6. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657-79.
7. Buckley R, Cobb MW, Ghurani S, Brock NF, Harford RR. Mycobacterium fortuitum infection occurring after a punch biopsy procedure. Pediatr Dermatol 1997;14:290-2.
8. Nagore E, Ramos P, Botella-Estrada R, Ramos-Niguez JA, Sanmartin O, Castejon P. Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen. Acta Derm Venereol (Stockl) 2001;81:291-3.
9. Friedel J, Piemont Y, Truchetet F, Cattan E. Mésothérapie et mycobactériose cutanée à Mycobacterium fortuitum: une médecine douce à risque. Ann Dermatol Venereol 1987;114:845-9.
10. Wallace RJ, Swenson JM, Silcox VA, Bullen MG. Treatment of non pulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibility. J Infect Dis 1985;152:500-14.
11. Wallace RJ. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria. Eur J Clin Microbiot Infect Dis 1994;13:953-60.
12. Fujita N, Utani A, Matsumoto F, Matsushima H, Kakuta M, Hatamochi A, Shinkai H. Levofloxacin alone efficiently treated a cutaneous Mycobacterium fortuitum infection. J Dermatol 2002;29:452-4.
13. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarythromycin, against Mycobacterium fortuitum, Mycobacterium chelonae and M. chelonae like organisms. Antimicrob Agents Chemother 1992;36:180-4.
14. Rapp RP, McCraney SA, Goodman NL, Shaddick DJ. New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. Ann Pharmacother 1994;28:1255-63.
15. Wallace RJ, Bedsole J, Sumter G, Sanders CV, Steele LC, Brown BA et al. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 1990;34:65-70.